deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT03339700

Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia

Addition of Gemcitabine to the Standard Reduced Busulfan and Cyclophosphamide (BUCY2) Pre Allogeneic Hematopoietic Stem Cell Transplantation Conditioning for Acute Lymphoblastic Leukemia

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Conditions Acute Lymphoblastic Leukemia, Adult
Interventions Allogeneic Hematopoietic Stem Cell Transplantation Busulfan Cyclophosphamide Gemcitabine
Updated 8 times since 2017 Last updated: Jan 10, 2020 Started: Sep 15, 2018 Primary completion: Sep 30, 2020 Completion: Sep 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Acute Lymphoblastic Leukemia, Adult, this trial is ongoing. The trial is conducted by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran and has accumulated 8 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Dec 2017 – ~Mar 2019 · 15 months · monthly snapshotRecruiting~Mar 2019 – ~May 2019 · 2 months · monthly snapshotRecruiting~May 2019 – ~Feb 2020 · 9 months · monthly snapshotRecruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotRecruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Mar 2022 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Mar 2022 [monthly]

    Recruiting PHASE2

  5. Feb 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

▶ Show 3 earlier versions

  1. May 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

    Phase: EARLY_PHASE1 → PHASE2

  2. Mar 2019 — May 2019 [monthly]

    Recruiting EARLY_PHASE1

  3. Dec 2017 — Mar 2019 [monthly]

    Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Data source: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations